drugset / Trial / NCT05470465

Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation

NCT05470465

RandomizedCrossoverQuadruple-blindOther

Summary

This study is designed to evaluate the effects of the coadministration of paroxetine or escitalopram with an opioid on ventilation. Ventilation will be assessed using a rebreathing methodology. This study will evaluate chronic and acute dosing of paroxetine and escitalopram combined with an opioid as well as chronic and acute dosing of the two drugs without coadministration of an opioid. This study is a 3-period, randomized, placebo-controlled crossover study conducted with 25 healthy participants. Each participant will receive each of the 3 treatments (placebo/oxycodone, paroxetine/oxycodone, escitalopram/oxycodone) in a randomized order.

Timeline

Start
2022-09-01
Primary completion
2023-09-17
Completion
2023-09-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 30 mg
Subject Paroxetine Small molecule 60 mg
Background Oxycodone Other / unclassified 10 mg